Literature DB >> 19454093

Seborrhoeic dermatitis.

Juan Jorge Manríquez1, Pablo Uribe.   

Abstract

INTRODUCTION: Seborrhoeic dermatitis affects at least 1-3% of the population. Malassezia (Pityrosporum) ovale is thought to be the causative organism, and causes inflammation involving T cells and complement. Seborrhoeic dermatitis tends to relapse after treatment. METHODS AND OUTCOMES: We conducted a systematic review and aimed to answer the following clinical questions: What are the effects of topical treatments for seborrhoeic dermatitis of the scalp in adults? What are the effects of topical treatments for seborrhoeic dermatitis of the face and body in adults? We searched: Medline, Embase, The Cochrane Library and other important databases up to February 2006 (Clinical Evidence reviews are updated periodically, please check our website for the most up-to-date version of this review). We included harms alerts from relevant organisations such as the US Food and Drug Administration (FDA) and the UK Medicines and Healthcare products Regulatory Agency (MHRA).
RESULTS: We found nine systematic reviews, RCTs, or observational studies that met our inclusion criteria. We performed a GRADE evaluation of the quality of evidence for interventions.
CONCLUSIONS: In this systematic review we present information relating to the effectiveness and safety of the following interventions: bifonazole, emollients, ketoconazole, lithium succinate, selenium sulphide, tar shampoo, terbinafine, and topical steroids (betamethasone valerate, clobetasol propionate, clobetasone butyrate, hydrocortisone, mometasone furate).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 19454093      PMCID: PMC2943817     

Source DB:  PubMed          Journal:  BMJ Clin Evid        ISSN: 1462-3846


  13 in total

1.  Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream.

Authors:  R B Skinner; P W Noah; R M Taylor; M D Zanolli; S West; J D Guin; E W Rosenberg
Journal:  J Am Acad Dermatol       Date:  1985-05       Impact factor: 11.527

2.  Skin lesions in chronic alcoholic pancreatitis.

Authors:  A Barba; W Piubello; I Vantini; S Caliari; R Cocchetto; P Vallaperta; L A Scuro; A Sapuppo; G Cavallini
Journal:  Dermatologica       Date:  1982-05

3.  Use of topical lithium succinate in the treatment of seborrhoeic dermatitis.

Authors:  C Cuelenaere; J De Bersaques; A Kint
Journal:  Dermatology       Date:  1992       Impact factor: 5.366

4.  Comparative efficacy and safety of bifonazole 1% cream and the corresponding base preparation in the treatment of seborrhoeic dermatitis.

Authors:  H Zienicke; H C Korting; O Braun-Falco; I Effendy; M Hagedorn; B Küchmeister; C Meisel
Journal:  Mycoses       Date:  1993 Sep-Oct       Impact factor: 4.377

5.  Treatment of seborrhoeic dermatitis with ketoconazole: I. Response of seborrhoeic dermatitis of the scalp to topical ketoconazole.

Authors:  M M Carr; D M Pryce; F A Ive
Journal:  Br J Dermatol       Date:  1987-02       Impact factor: 9.302

6.  Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole.

Authors:  C A Green; P M Farr; S Shuster
Journal:  Br J Dermatol       Date:  1987-02       Impact factor: 9.302

7.  Treatment with bifonazole shampoo for seborrhea and seborrheic dermatitis: a randomized, double-blind study.

Authors:  R Segal; M David; A Ingber; R Lurie; M Sandbank
Journal:  Acta Derm Venereol       Date:  1992-11       Impact factor: 4.437

Review 8.  Seborrheic dermatitis.

Authors:  Aditya K Gupta; Robyn Bluhm; Elizabeth A Cooper; Richard C Summerbell; Roma Batra
Journal:  Dermatol Clin       Date:  2003-07       Impact factor: 3.478

9.  A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff.

Authors:  F W Danby; W S Maddin; L J Margesson; D Rosenthal
Journal:  J Am Acad Dermatol       Date:  1993-12       Impact factor: 11.527

10.  Cutaneous manifestations of early human immunodeficiency virus exposure.

Authors:  R S Berger; M F Stoner; E R Hobbs; T J Hayes; R N Boswell
Journal:  J Am Acad Dermatol       Date:  1988-08       Impact factor: 11.527

View more
  1 in total

1.  Comparing the efficacy of Emu oil with clotrimazole and hydrocortisone in the treatment of seborrheic dermatitis: A clinical trial.

Authors:  Yalda Attarzadeh; Ali Asilian; Zabihollah Shahmoradi; Neda Adibi
Journal:  J Res Med Sci       Date:  2013-06       Impact factor: 1.852

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.